Riskpilot← Back to searchSign inGet full accessCELGENE ApS
APSIn liquidationCVR 30497147Hummeltoftevej 49Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20072 employees
Revenue 2024
DKK 2,8M
-65% vs 2023
EBITDA margin
80.9%
-53% vs 2023
Equity ratio
98.7%
Financial strength
Net profit 2024
DKK 3,5M
-6% vs 2023
| Revenue | DKK 2,8M | -65% |
| EBITDA | DKK 2,3M | -53% |
| Net profit | DKK 3,5M | -6% |
| Total assets | DKK 93,5M | -12% |
| Equity | DKK 92,3M | +4% |
| Employees | 2 | — |
Legal name
CELGENE ApS
CVR number
30497147
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
20. marts 2007
Share capital
DKK 100.000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Address
Hummeltoftevej 49
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 37.066 | 36.749 | 41.936 | 34.799 | 28.088 | 17.369 | 29.776 | 21.458 | 27.242 | 20.245 | 10.115 | 8.163 | 2.822 |
| Staff expenses | -15.133 | -14.353 | -15.302 | -18.467 | -17.451 | -10.778 | -19.150 | -10.120 | -8.548 | -6.938 | -4.739 | -3.268 | -539 |
| EBITDA | 8.301 | 7.051 | 9.039 | 2.975 | 10.636 | 6.591 | 10.626 | 11.338 | 18.694 | 13.306 | 5.376 | 4.895 | 2.282 |
| Depreciation & amort. | -330 | -317 | -138 | -81 | -105 | -96 | -70 | -59 | -40 | -0 | -0 | -0 | -0 |
| EBIT | 7.972 | 6.734 | 8.900 | 2.894 | 10.531 | 6.495 | 10.556 | 11.279 | 18.654 | 13.306 | 5.376 | 4.895 | 2.282 |
| Net financials | -33 | 23 | -343 | -145 | -220 | -445 | 6 | -31 | -164 | -16 | -23 | -50 | 2.386 |
| Profit before tax | 7.938 | 6.757 | 9.243 | 2.750 | 10.311 | 6.051 | 10.562 | 11.248 | 18.489 | 13.291 | 5.352 | 4.846 | 4.669 |
| Tax | 2.147 | 1.819 | 2.310 | 939 | 2.327 | 1.370 | 2.365 | 2.547 | 4.778 | 2.305 | 1.266 | 1.096 | 1.137 |
| Net profit | 5.791 | 4.939 | 6.934 | 1.811 | 7.984 | 4.681 | 8.197 | 8.701 | 13.711 | 10.986 | 4.086 | 3.750 | 3.532 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 32.529 | 56.750 | 58.296 | 74.652 | 94.540 | 64.239 | 80.180 | 143.573 | 163.319 | 129.403 | 104.448 | 106.098 | 93.462 |
| Equity | 12.952 | 17.891 | 24.824 | 26.636 | 34.619 | 39.300 | 47.497 | 56.198 | 69.910 | 80.895 | 84.981 | 88.731 | 92.263 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 374 | 641 | 0 | 0 | 0 | 0 |
| Short-term debt | 19.577 | 38.859 | 33.472 | 48.017 | 59.921 | 24.939 | 32.683 | 87.001 | 92.769 | 48.507 | 19.466 | 17.367 | 1.199 |
| Total debt | 19.577 | 38.859 | 33.472 | 48.017 | 59.921 | 24.939 | 32.683 | 87.375 | 93.409 | 48.507 | 19.466 | 17.367 | 1.199 |
EBITDA margin
80.9%
This company
15.8%
Market median
+412% vs market
20122024
Equity ratio
98.7%
This company
38.2%
Market median
+158% vs market
20122024
Return on equity
3.8%
This company
18.4%
Market median
-79% vs market
20122024
Net profit margin
125.2%
This company
8.1%
Market median
+1446% vs market
20122024
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20122024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CN Founder | Founder | 2007 | — | — |
TO Management | Management | 2007 | — | — |
HW Unofficial title | Unofficial title | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2007 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2012 | — | — | |
| Chairman | 2012 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairman | 2012 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2008 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2012 | — | — | |
| Chairman | 2019 | — | — | |
| Chairman | 2015 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2007 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CELGENE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| CELGENE NETHERLANDS BV | Founder | 0 companies |
| Tomas Olof Leander Gloveus | Management | 0 companies |
| Helen Wilhelmsson | Unofficial title | 0 companies |
| Patrick Eugene Flanigan III | Board of Directors | 0 companies |
| Alan Colowick | Board of Directors | 0 companies |
| Tuomo Tapani Pätsi | Board of Directors | 0 companies |
| Stéphane Jacques C. Strebelle | Board of Directors | 0 companies |
| Jörg Boris Schulze | Board of Directors | 0 companies |
| Tuomo Patsi | Chairman | 0 companies |
| Jürg Oehen | Board of Directors | 0 companies |
| Nakisa Serry | Board of Directors | 0 companies |
| Aart Brouwer | Board of Directors | 0 companies |
| Philippe M. M. J. Van Holle | Board of Directors | 0 companies |
| Swati Mehta | Board of Directors | 0 companies |
| Anders Thelborg | Chairman | 0 companies |
| Sandesh Mahatme | Board of Directors | 0 companies |
| Iddo Leshem | Board of Directors | 0 companies |
| Robertus Johannes van Son | Chairman | 0 companies |
| Wim J. M. G. Souverijns | Chairman | 0 companies |
| Jonathan Biller | Board of Directors | 0 companies |
| Katherine Reynolds Kelly | Board of Directors | 0 companies |
| Wim J. M. G. Souverijns | Chairman | 0 companies |
| Stephen Edward Jasko | Board of Directors | 0 companies |
| Andre L. E. M. van Hoek | Board of Directors | 0 companies |
| David Walter Pignolet | Board of Directors | 0 companies |
| Anna Katarina Edsfors Åleskog | Board of Directors | 0 companies |
| Daniel Bazarko | Board of Directors | 0 companies |
| Michael Guislain Lugez | Chairman | 0 companies |
| Nicolas Francois R. Verbeke | Chairman | 0 companies |
| Abdelhamid Chaaibi | Board of Directors | 0 companies |